Atricure to participate in the 42nd annual j.p. morgan healthcare conference

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that the company will be participating in the upcoming 42nd annual j.p. morgan healthcare conference. atricure's management is scheduled to present on wednesday, january 10, 2024, at 7:30 a.m. pacific standard time. interested parties may access a live audio webcast by v.
ATRC Ratings Summary
ATRC Quant Ranking